Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02857738 · ClinicalTrials.gov registry record · NA
Sun Protection Factor (SPF) - Static and Water Resistant Assay
A NA study of Sunscreen Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02857738: Completed NA study of Sunscreen Agents, sponsored by Bayer.
NCT02857738 is a NA study of Sunscreen Agents that has completed, run by Bayer. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02857738, a NA study of Sunscreen Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.
Conditions Studied
Interventions
- DRUG BAY 987519
- DRUG SPF 15 Control
Study Locations (1)
New Jersey
- - Union
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-05-26 |
| Est. Completion | 2015-06-10 |
| Phase | NA |
What the finished NCT02857738 record still lists
NCT02857738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Sunscreen Agents appearing as the primary indexed condition, and to 2 interventions - of which BAY 987519 is the first listed.
NCT02857738 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02857738 about?
NCT02857738 is a clinical study titled "Sun Protection Factor (SPF) - Static and Water Resistant Assay". Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.
What is the current status of trial NCT02857738?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-05-26. Estimated completion is 2015-06-10.
What conditions does trial NCT02857738 study?
This clinical trial studies the following conditions: Sunscreen Agents.
What interventions are being tested in trial NCT02857738?
The interventions under investigation include: BAY 987519 (DRUG), SPF 15 Control (DRUG).
Who is sponsoring clinical trial NCT02857738?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02857738 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreen Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02857738's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI